Unraveling the role of microRNAs: potential biomarkers for gestational diabetes mellitus revealed through RNA sequencing analysis
Archives of Gynecology and Obstetrics · 30.05.2024 · 310 (2) · 1255-1264
DOI: 10.1007/s00404-024-07518-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 30.05.2024. Verfasst von Huizhen Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Hospital of Putian, Teaching Hospital, Fujian Medical University, Putian, 351100, China. Hauptthemen laut MEDLINE: Diabetes, Gestational, MicroRNAs, Biomarkers, Sequence Analysis, RNA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Startup Fund for Advanced Talents of Putian University, Research Projects of Putian University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Gestational diabetes mellitus (GDM) poses significant health risks for both mothers and children, contributing to long-term complications such as type 2 diabetes and cardiovascular disease. This study explores the potential of microRNAs (miRNAs) as biomarkers for GDM by analyzing peripheral blood samples from GDM patients.
Method
Ten samples, including peripheral blood from 5 GDM patients and 5 controls, were collected to perform the RNA sequencing analysis. Differentially expressed miRNAs were further validated by quantitative real-time polymerase chain reaction.
Results
A total of 2287 miRNAs were identified, 229 of which showed differential expression. Validation by qRT-PCR confirmed significant up-regulation of miR-5193, miR-5003-3p, miR-3127-5p, novel-miR-96, miR-6734-5p, and miR-122-5p, while miR-10395-3p was down-regulated. Bioinformatics analyses revealed the involvement of these miRNAs in pathways associated with herpes simplex virus 1 infection.
Conclusion
This study provides insights into the differential expression of miRNAs in GDM patients and their potential roles in disease pathogenesis. It suggests that the differentially expressed miRNAs could serve as potential biomarkers for GDM, shedding light on the complex molecular mechanisms involved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The First Hospital of Putian, Teaching Hospital, Fujian Medical University, Putian, 351100, China.
- Key Laboratory of Translational Tumor Medicine in Fujian Province, Putian University, School of Basic Medicine Science, Putian, 351100, Fujian, China.
- Key Laboratory of Translational Tumor Medicine in Fujian Province, Putian University, School of Basic Medicine Science, Putian, 351100, Fujian, China. plar000@163.com.
ORCID-Profile: Si Pan
Förderung
- Startup Fund for Advanced Talents of Putian University
- Research Projects of Putian University
Zitieren
APA
Lin, H., Chen, X., Wang, L., Zhu, T., Feng, X., Liu, X., Chen, H., & Pan, S. (2024). Unraveling the role of microRNAs: potential biomarkers for gestational diabetes mellitus revealed through RNA sequencing analysis. Archives of Gynecology and Obstetrics, 310(2), 1255-1264. https://doi.org/10.1007/s00404-024-07518-x
Vancouver
Lin H, Chen X, Wang L, Zhu T, Feng X, Liu X, et al. Unraveling the role of microRNAs: potential biomarkers for gestational diabetes mellitus revealed through RNA sequencing analysis. Archives of Gynecology and Obstetrics. 2024;310(2):1255-1264. doi:10.1007/s00404-024-07518-x
BibTeX
@article{Lin2024,
author = {Lin, Huizhen and Chen, Xiao and Wang, Lisui and Zhu, Tang and Feng, Xiaohui and Liu, Xiaomei and Chen, Haiying and Pan, Si},
title = {Unraveling the role of microRNAs: potential biomarkers for gestational diabetes mellitus revealed through RNA sequencing analysis},
journal = {Archives of Gynecology and Obstetrics},
year = {2024},
volume = {310},
number = {2},
pages = {1255--1264},
doi = {10.1007/s00404-024-07518-x}
}
EUVIMED